THERAVANCE BIOPHARMA INC

TBPHNASDAQ

🏆 #2438 by market capEarnings Nov 9US Equity

$759.75▲ $7.90 (+1.04%)

Simulated price

1h—

24h▲ 1.0%

7d—

14d—

30d—

1y—

🏦Market Cap

$877M

Small Cap

📈Revenue Growth (YoY)

+68.2%

High Growth

📊Gross Margin

100.0%

High

💵FCF Margin

256.3%

Strong

⚖️P/S Ratio

8.0x

Fair

Otter Score

54

Weak

🔭

No analyst ratings for TBPH

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.